Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
Clinical trial NCT05700955 · UNKNOWN
Trial details
- NCT number
- NCT05700955
- Sponsor
- University of Louisville
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2025-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.